Catalyst Pharmaceuticals (CPRX) Operating Income (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Operating Income of $73.23 million for Q1 2026, up 15.6% from $63.37 million a year earlier and up 18.4% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Catalyst Pharmaceuticals' Operating Income came in at $267.64 million, up 15.7% year-over-year; for FY2025, it was $257.78 million, up 32.1% from FY2024.
- Operating Income has a five-year compound annual growth rate of 44.2% (FY2020 to FY2025).
- By year, Operating Income came in at $195.12 million in FY2024 (+124.8%), $86.81 million in FY2023 (-14.8%), $101.84 million in FY2022 (+94.4%) and $52.39 million in FY2021 (+26.8%).
- The Q1 2026 figure ranks as the highest quarterly Operating Income in data going back to Q3 2010.
- Year over year, Operating Income gained in six of the last seven quarters, with growth averaging 38.1%.
- The high point for year-over-year Operating Income in five years was Q4 2022 (growth of 141.7%); the low point was Q1 2024 (a decline of 23.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $61.85 million (Q4 2025), $66.27 million (Q3 2025) and $66.3 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 73.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 73.23 Mn |
| Dec 31, 2025 | 61.85 Mn |
| Sep 30, 2025 | 66.27 Mn |
| Jun 30, 2025 | 66.30 Mn |
| Mar 31, 2025 | 63.37 Mn |
| Dec 31, 2024 | 62.84 Mn |
| Sep 30, 2024 | 50.91 Mn |
| Jun 30, 2024 | 54.25 Mn |
| Mar 31, 2024 | 27.13 Mn |
| Dec 31, 2023 | 41.69 Mn |
| Sep 30, 2023 | -37.19 Mn |
| Jun 30, 2023 | 46.70 Mn |
| Mar 31, 2023 | 35.61 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 25.10 Mn |
| Jun 30, 2022 | 28.57 Mn |
| Mar 31, 2022 | 17.37 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Sep 30, 2021 | 14.00 Mn |
| Jun 30, 2021 | 15.84 Mn |
API Access
Catalyst Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();